You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

Looking to optimise around respiratory?

View the case studies below to see how other health economies have utilised the Ellipta range of medicines to optimise respiratory outcomes.

The role of bronchodilators in the treatment of COPD: An interview with Dr. Owen Johnson.

Download PDF


GSK can provide a range of patient support items for your respiratory patients. Please follow this link to find out more

> View resources


  1. Asthma Control Test. January 2017. Available from: [accessed August 2018].

Ellipta is a registered trademark of the GlaxoSmithKline group of companies